United States · FDA National Drug Code directory

Valsartan and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 33342-076_a1b947a6-e356-4442-9df7-9e82b299a852
Product NDC: 33342-076
Form: TABLET
Composition / generic term: Valsartan and Hydrochlorothiazide
Labeler: Macleods Pharmaceuticals Limited
Marketing category: ANDA
Marketing start / end (source format): 20130419
Source listing expiry: 20261231

Source-listed ingredients

VALSARTAN — 160 mg/1
HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET in 1 BOTTLE (33342-076-10) · 33342-076-10
500 TABLET in 1 BOTTLE (33342-076-15) · 33342-076-15

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →